Metastatic Brain Tumours from Oesophageal Carcinoma: Neuro-Imaging and Clinicopathological Characteristics in Japanese Patients

被引：0
|
作者：
H. Takeshima
J. Kuratsu
T. Nishi
N. Soyama
M. Miura
T. Masumitsu
Y. Ushio
机构：
[1] Department of Neurosurgery,
[2] Faculty of Medicine,undefined
[3] Kagoshima University,undefined
[4] Kagoshima,undefined
[5] Japan,undefined
[6] Department of Neurosurgery,undefined
[7] Kumamoto University School of Medicine,undefined
[8] Kumamoto,undefined
[9] Japan,undefined
[10] Kyushu Memorial Hospital,undefined
[11] Kumamoto,undefined
[12] Japan,undefined
[13] Kumamoto City Hospital,undefined
[14] Kumamoto,undefined
[15] Japan,undefined
[16] Taragi Municipal Hospital,undefined
[17] Taragi,undefined
[18] Japan,undefined
来源：
Acta Neurochirurgica | 2001年 / 143卷
关键词：
Keywords: Metastatic brain tumour; esophageal carcinoma; neuro-imaging.;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
 Background. Since metastatic brain tumours from esophageal carcinoma are essentially rare, previous reports have not determined the common neuro-radiological findings and its clinical aspects.
引用
收藏
页码：31 / 36
页数：5
相关论文
共 50 条
  • [21] Clinicopathological Features and Prognoses in Patients With Brain Metastases From Small-Cell Esophageal Carcinoma: A Retrospective Analysis of 18 Patients
    Jiao, Wenpeng
    Lin, Chi
    Xiao, Linlin
    Zhang, Xinyuan
    Hu, Mengzhu
    Zhao, Min
    Wang, Jun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [22] Patients with brain metastases from advanced or metastatic renal cell carcinoma - Data from the clinical RCC Registry
    Mueller, L.
    Goebell, P. J.
    Reichert, D.
    Krieger, J. -U
    Jaenicke, M.
    Harde, J.
    Koska, M.
    Marschner, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 91 - 91
  • [23] Prevalence and clinicopathological/molecular characteristics of mismatch repair protein-deficient tumours among surgically treated patients with prostate cancer in a Japanese hospital-based population
    Kagawa, Makoto
    Kawakami, Satoru
    Yamamoto, Azusa
    Suzuki, Okihide
    Eguchi, Hidetaka
    Okazaki, Yasushi
    Akagi, Kiwamu
    Tamaru, Jun-ichi
    Arai, Tomio
    Yamaguchi, Tatsuro
    Ishida, Hideyuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (04) : 639 - 645
  • [24] Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group
    Camidge, D. Ross
    Lee, Eudocia Q.
    Lin, Nancy U.
    Margolin, Kim
    Ahluwalia, Manmeet S.
    Bendszus, Martin
    Chang, Susan M.
    Dancey, Janet
    de Vries, Elisabeth G. E.
    Harris, Gordon J.
    Hodi, F. Stephen
    Lassman, Andrew B.
    Macdonald, David R.
    Peereboom, David M.
    Schiff, David
    Soffietti, Ricardo
    van den Bent, Martin J.
    Wefel, Jeffrey S.
    Wen, Patrick Y.
    LANCET ONCOLOGY, 2018, 19 (01): : E20 - E32
  • [25] Clinicopathological characteristics and outcomes in patients with lung metastases from differentiated thyroid carcinoma following 131I therapy
    Sun Yungang
    Ouyang, Wei
    Feng, Huijuan
    Wu, Juqing
    Chen, Pan
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [26] Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association
    Kanayama, Hiro-omi
    Fukumori, Tomoharu
    Fujimoto, Hiroyuki
    Nakanishi, Hiroyuki
    Ohyama, Chikara
    Suzuki, Kazuhiro
    Nishiyama, Hiroyuki
    Eto, Masatoshi
    Miki, Tsuneharu
    Kamoi, Kazumi
    Kubota, Yoshinobu
    Takahashi, Satoru
    Homma, Yukio
    Naito, Seiji
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (09) : S1 - S7
  • [27] Overall Survival and Updated Results from a Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma
    Tomita, Yoshihiko
    Shinohara, Nobuo
    Yuasa, Takeshi
    Fujimoto, Hiroyuki
    Niwakawa, Masashi
    Mugiya, Soichi
    Miki, Tsuneharu
    Uemura, Hirotsugu
    Nonomura, Norio
    Takahashi, Masayuki
    Hasegawa, Yoshihiro
    Agata, Naoki
    Houk, Brett
    Naito, Seiji
    Akaza, Hideyuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (12) : 1166 - 1172
  • [28] Clinicopathological Characteristics and Real-life Data of Patients Receiving Tyrosine Kinase Inhibitor in Metastatic EGFR Mutant Non-small Cell Lung Carcinoma
    Ekinci, Baris
    Demirci, Nebi Serkan
    NAMIK KEMAL MEDICAL JOURNAL, 2023, 11 (04): : 385 - 394
  • [29] Phase III Trial of Everolimus in Metastatic Renal Cell Carcinoma: Subgroup Analysis of Japanese Patients from RECORD-1
    Tsukamoto, Taiji
    Shinohara, Nobuo
    Tsuchiya, Norihiko
    Hamamoto, Yasuo
    Maruoka, Masayuki
    Fujimoto, Hiroyuki
    Niwakawa, Masashi
    Uemura, Hirotsugu
    Usami, Michiyuki
    Terai, Akito
    Kanayama, Hiro-omi
    Sumiyoshi, Yoshiteru
    Eto, Masatoshi
    Akaza, Hideyuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (01) : 17 - 24
  • [30] Prognostic Factors of Survival for Patients With Metastatic Renal Cell Carcinoma With Brain Metastases Treated With Targeted Therapy: Results From the International Metastatic Renal Cell Carcinoma Database Consortium
    Vickers, Michael M.
    Al-Harbi, Hulayel
    Choueiri, Toni K.
    Kollmannsberger, Christian
    North, Scott
    MacKenzie, Mary
    Knox, Jennifer J.
    Rini, Brian I.
    Heng, Daniel Y. C.
    CLINICAL GENITOURINARY CANCER, 2013, 11 (03) : 311 - 315
12345